These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10727436)

  • 1. The lipid-laden foam cell: an elusive target for therapeutic intervention.
    Brewer HB
    J Clin Invest; 2000 Mar; 105(6):703-5. PubMed ID: 10727436
    [No Abstract]   [Full Text] [Related]  

  • 2. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.
    Accad M; Smith SJ; Newland DL; Sanan DA; King LE; Linton MF; Fazio S; Farese RV
    J Clin Invest; 2000 Mar; 105(6):711-9. PubMed ID: 10727439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
    Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia.
    Ohshiro T; Matsuda D; Sakai K; Degirolamo C; Yagyu H; Rudel LL; Omura S; Ishibashi S; Tomoda H
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1108-15. PubMed ID: 21393580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.
    Miyazaki A; Sakai M; Sakamoto Y; Horiuchi S
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1095-9. PubMed ID: 14582454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Roles of acyl-coenzyme A: cholesterol acyltransferase (ACAT) isozymes].
    Miyazaki A; Horiuchi S
    Tanpakushitsu Kakusan Koso; 1999 Jun; 44(8 Suppl):1312-8. PubMed ID: 10397022
    [No Abstract]   [Full Text] [Related]  

  • 7. Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis.
    Perrey S; Legendre C; Matsuura A; Guffroy C; Binet J; Ohbayashi S; Tanaka T; Ortuno JC; Matsukura T; Laugel T; Padovani P; Bellamy F; Edgar AD
    Atherosclerosis; 2001 Apr; 155(2):359-70. PubMed ID: 11254906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACAT1 deletion in murine macrophages associated with cytotoxicity and decreased expression of collagen type 3A1.
    Rodriguez A; Ashen MD; Chen ES
    Biochem Biophys Res Commun; 2005 May; 331(1):61-8. PubMed ID: 15845358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
    Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
    Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages.
    Fazio S; Major AS; Swift LL; Gleaves LA; Accad M; Linton MF; Farese RV
    J Clin Invest; 2001 Jan; 107(2):163-71. PubMed ID: 11160132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol esters and atherosclerosis-a game of ACAT and mouse.
    Rudel LL; Shelness GS
    Nat Med; 2000 Dec; 6(12):1313-4. PubMed ID: 11100106
    [No Abstract]   [Full Text] [Related]  

  • 12. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis.
    Ricci R; Sumara G; Sumara I; Rozenberg I; Kurrer M; Akhmedov A; Hersberger M; Eriksson U; Eberli FR; Becher B; Borén J; Chen M; Cybulsky MI; Moore KJ; Freeman MW; Wagner EF; Matter CM; Lüscher TF
    Science; 2004 Nov; 306(5701):1558-61. PubMed ID: 15567863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage cholesterol balance. A potential site of genetic control of susceptibility to atherosclerosis.
    St Clair RW; Yancey PG; Leight MA
    Ann N Y Acad Sci; 1995 Jan; 748():264-75; discussion 275-6. PubMed ID: 7695170
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
    Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M
    Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol.
    Tabas I
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S12-6. PubMed ID: 15143347
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner.
    Zhao Z; de Beer MC; Cai L; Asmis R; de Beer FC; de Villiers WJ; van der Westhuyzen DR
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):168-73. PubMed ID: 15514202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasone.
    Yang L; Yang JB; Chen J; Yu GY; Zhou P; Lei L; Wang ZZ; Cy Chang C; Yang XY; Chang TY; Li BL
    Cell Res; 2004 Aug; 14(4):315-23. PubMed ID: 15353128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation.
    Rong JX; Kusunoki J; Oelkers P; Sturley SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):122-7. PubMed ID: 15499046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress.
    Meir KS; Leitersdorf E
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1006-14. PubMed ID: 15087308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.